471 related articles for article (PubMed ID: 27605433)
1. Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Greening DW; Ji H; Chen M; Robinson BW; Dick IM; Creaney J; Simpson RJ
Sci Rep; 2016 Sep; 6():32643. PubMed ID: 27605433
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic and Non-Malignant Pancreatic Exosome Cargo Reveal Distinct Expression of Oncogenic and Prognostic Factors Involved in Tumor Invasion and Metastasis.
Emmanouilidi A; Paladin D; Greening DW; Falasca M
Proteomics; 2019 Apr; 19(8):e1800158. PubMed ID: 30893511
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of Small Extracellular Vesicles Secreted by Human Pancreatic Cancer Cells Implicated in Cellular Transformation.
Servage KA; Stefanius K; Gray HF; Orth K
Sci Rep; 2020 May; 10(1):7713. PubMed ID: 32382024
[TBL] [Abstract][Full Text] [Related]
4. Exosomes: Key mediators of metastasis and pre-metastatic niche formation.
Lobb RJ; Lima LG; Möller A
Semin Cell Dev Biol; 2017 Jul; 67():3-10. PubMed ID: 28077297
[TBL] [Abstract][Full Text] [Related]
5. The Influence of a Stressful Microenvironment on Tumor Exosomes: A Focus on the DNA Cargo.
Domenis R; Cifù A; Curcio F
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227947
[TBL] [Abstract][Full Text] [Related]
6. Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication.
Monaco F; Gaetani S; Alessandrini F; Tagliabracci A; Bracci M; Valentino M; Neuzil J; Amati M; Bovenzi M; Tomasetti M; Santarelli L
Cancer Lett; 2019 Oct; 463():27-36. PubMed ID: 31400405
[TBL] [Abstract][Full Text] [Related]
7. A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.
Creaney J; Dick IM; Leon JS; Robinson BW
Cancer Genomics Proteomics; 2017; 14(2):103-117. PubMed ID: 28387650
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miR-16-5p as a target for malignant mesothelioma.
Munson PB; Hall EM; Farina NH; Pass HI; Shukla A
Sci Rep; 2019 Aug; 9(1):11688. PubMed ID: 31406207
[TBL] [Abstract][Full Text] [Related]
9. Exosomes in cancer development.
Stefanius K; Servage K; Orth K
Curr Opin Genet Dev; 2021 Feb; 66():83-92. PubMed ID: 33477017
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of exosomes reveals an association between cell invasiveness and exosomal bioactivity on endothelial and mesenchymal cell migration
Sharma S; Alharbi M; Kobayashi M; Lai A; Guanzon D; Zuñiga F; Ormazabal V; Palma C; Scholz-Romero K; Rice GE; Hooper JD; Salomon C
Clin Sci (Lond); 2018 Sep; 132(18):2029-2044. PubMed ID: 30219799
[TBL] [Abstract][Full Text] [Related]
11. The secretome signature of malignant mesothelioma cell lines.
Manfredi M; Martinotti S; Gosetti F; Ranzato E; Marengo E
J Proteomics; 2016 Aug; 145():3-10. PubMed ID: 26921831
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
13. Exosomes in cancer: Small transporters with big functions.
Li X; Wang Y; Wang Q; Liu Y; Bao W; Wu S
Cancer Lett; 2018 Oct; 435():55-65. PubMed ID: 30071288
[TBL] [Abstract][Full Text] [Related]
14. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Lazar I; Clement E; Ducoux-Petit M; Denat L; Soldan V; Dauvillier S; Balor S; Burlet-Schiltz O; Larue L; Muller C; Nieto L
Pigment Cell Melanoma Res; 2015 Jul; 28(4):464-75. PubMed ID: 25950383
[TBL] [Abstract][Full Text] [Related]
15. Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
Clark DJ; Fondrie WE; Yang A; Mao L
J Proteomics; 2016 Feb; 133():161-169. PubMed ID: 26739763
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A review.
Ahmadzada T; Kao S; Reid G; Clarke S; Grau GE; Hosseini-Beheshti E
Crit Rev Oncol Hematol; 2020 Jun; 150():102949. PubMed ID: 32330840
[TBL] [Abstract][Full Text] [Related]
17. Exosomes in virus-associated cancer.
Wu J; Yang J; Ding J; Guo X; Zhu XQ; Zheng Y
Cancer Lett; 2018 Dec; 438():44-51. PubMed ID: 30219505
[TBL] [Abstract][Full Text] [Related]
18. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles Isolated from Malignant Mesothelioma Cancer-Associated Fibroblasts Induce Pro-Oncogenic Changes in Healthy Mesothelial Cells.
Chernova T; Grosso S; Sun XM; Tenor AR; Cabeza JZ; Craxton A; Self EL; Nakas A; Cain K; MacFarlane M; Willis AE
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293328
[TBL] [Abstract][Full Text] [Related]
20. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis.
Rodrigues G; Hoshino A; Kenific CM; Matei IR; Steiner L; Freitas D; Kim HS; Oxley PR; Scandariato I; Casanova-Salas I; Dai J; Badwe CR; Gril B; Tešić Mark M; Dill BD; Molina H; Zhang H; Benito-Martin A; Bojmar L; Ararso Y; Offer K; LaPlant Q; Buehring W; Wang H; Jiang X; Lu TM; Liu Y; Sabari JK; Shin SJ; Narula N; Ginter PS; Rajasekhar VK; Healey JH; Meylan E; Costa-Silva B; Wang SE; Rafii S; Altorki NK; Rudin CM; Jones DR; Steeg PS; Peinado H; Ghajar CM; Bromberg J; de Sousa M; Pisapia D; Lyden D
Nat Cell Biol; 2019 Nov; 21(11):1403-1412. PubMed ID: 31685984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
